These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Atypical methotrexate dermatitis and vasculitis in a patient with ankylosing spondylitis.
    Author: Borman P, Bodur H, Güleç AT, Uçan H, Seçkin U, Mocan G.
    Journal: Rheumatol Int; 2000; 19(5):191-3. PubMed ID: 10984137.
    Abstract:
    Reports of histologically proven low-dose methotrexate (MTX)-induced vasculitis are uncommon and mostly found for patients with rheumatoid arthritis. Herein we present a patient with ankylosing spondylitis who developed large atypical erythematopurpuric cutaneous lesions after the second oral dose of 7.5 mg MTX therapy. The histological findings of a cutaneous lesion were consistent with vasculitis. The skin lesions regressed significantly after the discontinuation of MTX therapy. As the clinical picture of the patient's rheumatological condition became progressively severe, prednisolone therapy was initiated 8 days later and the skin rash resolved completely in a couple of weeks.
    [Abstract] [Full Text] [Related] [New Search]